# Safety of Vero Cell - Derived Inactivated Japanese Encephalitis Vaccine (JECEVAX) in Children From 9-24 Months of Age

> **NCT03204227** · PHASE2 · COMPLETED · sponsor: **National Institute of Hygiene and Epidemiology, Vietnam** · enrollment: 220 (actual)

## Conditions studied

- Japanese Encephalitis

## Interventions

- **BIOLOGICAL:** JEVAX
- **BIOLOGICAL:** JECEVAX

## Key facts

- **NCT ID:** NCT03204227
- **Lead sponsor:** National Institute of Hygiene and Epidemiology, Vietnam
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-02
- **Primary completion:** 2017-08-12
- **Final completion:** 2017-08-12
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2018-09-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03204227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03204227, "Safety of Vero Cell - Derived Inactivated Japanese Encephalitis Vaccine (JECEVAX) in Children From 9-24 Months of Age". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03204227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*